BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Allergy to pollen
,
Hippocampus
,
Biofuel
,
LEP
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hemoglobinuria
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Granulocytes of paroxysmal nocturnal hemoglobinuria patients, GPI-AP- and GPI-AP+ cells
OMIM - Anemia
Explore Curated Studies Results
Literature
Most Relevant Literature
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
Paroxysmal nocturnal hemoglobinuria: Where we stand.
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analy…
Pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
Paroxysmal nocturnal hemoglobinuria: Where are we going.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ